Success of COVID-19 antiviral pills hinges on access to speedy, accurate tests

Within a few weeks, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the COVID-19 pandemic — with a second option from Pfizer to follow shortly after.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this